IHAM
RXDX

Integral Health Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Integral Health Asset Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,000
Closed -$3.22M – 102
2023
Q1 		$3.22M Buy
30,000
+10,000
+50% +$1.07M 0.65% 53
2022
Q4 		$2.2M Buy
+20,000
New +$2.2M 0.46% 53